Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

被引:1011
作者
Laruelle, M
Abi-Dargham, A
vanDyck, CH
Gil, R
DSouza, CD
Erdos, J
McCance, E
Rosenblatt, W
Fingado, C
Zoghbi, SS
Baldwin, RM
Seibyl, JP
Krystal, JH
Charney, DS
Innis, RB
机构
[1] YALE UNIV, SCH MED, DEPT PSYCHIAT, NEW HAVEN, CT 06520 USA
[2] YALE UNIV, SCH MED, DEPT DIAGNOST RADIOL, NEW HAVEN, CT 06520 USA
[3] YALE UNIV, SCH MED, DEPT ANESTHESIOL, NEW HAVEN, CT 06520 USA
[4] VET AFFAIRS MED CTR, WEST HAVEN, CT 06516 USA
关键词
D O I
10.1073/pnas.93.17.9235
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dopamine hypothesis of schizophrenia proposes that hyperactivity of dopaminergic transmission is associated with this illness, but direct observation of abnormalities of dopamine function in schizophrenia has remained elusive, We used a newly developed single photon emission computerized tomography method to measure amphetamine-induced dopamine release in the striatum of fifteen patients with schizophrenia and fifteen healthy controls, Amphetamine-induced dopamine release was estimated by the amphetamine-induced reduction in dopamine D-2 receptor availability, measured as the binding potential of the specific D-2 receptor radiotracer [I-123] (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide ([I-123]IBZM), The amphetamine-induced decrease in [I-123]IBZM binding potential was significantly greater in the schizophrenic group (-19.5 +/- 4.1%) compared with the control group (-7.6 +/- 2.1%), In the schizophrenic group, elevated amphetamine effect on [I-123]IBZM binding potential was associated with emergence or worsening of positive psychotic symptoms, This result suggests that psychotic symptoms elicited in this experimental setting in schizophrenic patients are associated with exaggerated stimulation of dopaminergic transmission. Such an observation would be compatible with an abnormal responsiveness of dopaminergic neurons in schizophrenia.
引用
收藏
页码:9235 / 9240
页数:6
相关论文
共 51 条
[1]  
Angrist B M, 1970, Biol Psychiatry, V2, P95
[2]   SELECTIVITY OF RELEASE OF NOREPINEPHRINE, DOPAMINE AND 5-HYDROXYTRYPTAMINE BY AMPHETAMINE IN VARIOUS REGIONS OF RAT-BRAIN [J].
AZZARO, AJ ;
RUTLEDGE, CO .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (22) :2801-2813
[3]  
BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996
[4]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[5]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186
[6]  
CROSS AJ, 1983, J NEURAL TRANSM, P265
[7]  
DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474
[8]   PREFRONTAL CORTICAL DOPAMINE SYSTEMS AND THE ELABORATION OF FUNCTIONAL CORTICOSTRIATAL CIRCUITS - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
DEUTCH, AY .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (2-3) :197-221
[9]   MODULATION OF CENTRAL CHOLINERGIC ACTIVITY BY GABA AND SEROTONIN - PET STUDIES WITH C-11 BENZTROPINE IN PRIMATES [J].
DEWEY, SL ;
SMITH, GS ;
LOGAN, J ;
BRODIE, JD .
NEUROPSYCHOPHARMACOLOGY, 1993, 8 (04) :371-376
[10]  
FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213